Protagonist TherapeuticsPTGX
那斯達克 · USD
144.67
-1.27
(-0.87%)
盤中 09/10 01:29 (UTC+8)
09/10 01:29 (UTC+8)
Protagonist TherapeuticsPTGX
144.67
-1.27
(-0.87%)
財務數據
損益表
- 2.55
- 0.04
- 0.05
- 1.71
- 0.28
- 0.06
- 0.05
- 0.07
- 0.56
- 2.13
- 324.92
- -98.37
- 12.19
- 3550.01
- -83.40
- -80.42
- -15.04
- 57.83
- 657.94
- 278.72
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 213,475 | 56,368 | 7,437 | 4,712 | 5,546 | 28,321 | 170,638 | 4,675 | 4,167 | 254,953 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 213,475 | 56,368 | 7,437 | 4,712 | 5,546 | 28,321 | 170,638 | 4,675 | 4,167 | 254,953 |
營業費用 | 54,709 | 60,016 | 57,792 | 51,133 | 47,587 | 47,631 | 43,858 | 46,128 | 42,960 | 48,644 |
研發費用 | 42,061 | 46,739 | 46,358 | 40,003 | 37,036 | 35,893 | 34,904 | 35,970 | 33,520 | 33,734 |
推銷及管理費用 | 12,648 | 13,277 | 11,434 | 11,130 | 10,551 | 11,738 | 8,954 | 10,158 | 9,440 | 14,910 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 158,766 | -3,648 | -50,355 | -46,421 | -42,041 | -19,310 | 126,780 | -41,453 | -38,793 | 206,309 |
其他收入及費用 | 6,348 | 5,929 | 6,637 | 7,082 | 7,442 | 7,655 | 6,884 | 7,823 | 7,501 | 4,357 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 165,114 | 2,281 | -43,718 | -39,339 | -34,599 | -11,655 | 133,664 | -33,630 | -31,292 | 210,666 |
所得稅 | 2,265 | -1,502 | 666 | - | 172 | - | 1,990 | -420 | -676 | 3,326 |
稅後純益 | 162,849 | 3,783 | -44,384 | -39,339 | -34,771 | -11,655 | 131,674 | -33,210 | -30,616 | 207,340 |
基本每股稅後盈餘(元) | 2.47 | 0.06 | -0.69 | -0.62 | -0.55 | -0.19 | 2.11 | -0.54 | -0.50 | 3.41 |
稀釋每股稅後盈餘(元) | 2.30 | 0.05 | -0.70 | -0.62 | -0.55 | -0.19 | 2.01 | -0.55 | -0.49 | 3.26 |
基本平均股數(千股) | 65935.00 | 65087.00 | 64031.00 | 63772.00 | 63510.00 | 62963.00 | 62328.00 | 61767.00 | 61305.00 | 60855.00 |
稀釋平均股數(千股) | 71007.00 | 70492.00 | 64031.00 | 63772.00 | 63510.00 | 62963.00 | 66406.00 | 61767.00 | 61305.00 | 63595.00 |
還原基本每股稅後盈餘(元) | 2.47 | 0.06 | -0.69 | -0.62 | -0.55 | -0.19 | 2.11 | -0.54 | -0.50 | 3.41 |
還原稀釋每股稅後盈餘(元) | 2.30 | 0.05 | -0.70 | -0.62 | -0.55 | -0.19 | 2.01 | -0.55 | -0.49 | 3.26 |
還原基本平均股數(千股) | 65,935 | 65,087 | 64,031 | 63,772 | 63,510 | 62,963 | 62,328 | 61,767 | 61,305 | 60,855 |
還原稀釋平均股數(千股) | 71,007 | 70,492 | 64,031 | 63,772 | 63,510 | 62,963 | 66,406 | 61,767 | 61,305 | 63,595 |
EBITDA(千元) | 164,465 | 1,663 | -44,678 | -40,662 | -36,209 | -13,705 | 133,091 | -35,821 | -31,478 | 209,871 |